6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR
This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4 -yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and syn...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WILSHER, Nicola Elizabeth LINDLEY, Colin Thomas READER, Michael BAGULEY, Paul Anthony MELLING, Robert Craig SCARATI, Mirka SAUNDERS, Mark Henry ADAMCZYK, Bozena Ewa |
| description | This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4 -yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and synthetic intermediates for use in the process, and novel formulations containing the compound, as well as therapeutic uses of the compound. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3612524B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3612524B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3612524B13</originalsourceid><addsrcrecordid>eNrjZDAx0w2IDPL09XTx9NP1DPb39HPx93FVcHEN8gxzDPEMc1VwDFZwDfI21DdS8PTz8HTyDPEP4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxmaGRqZGJk6GxkQoAQBnsibB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR</title><source>esp@cenet</source><creator>WILSHER, Nicola Elizabeth ; LINDLEY, Colin Thomas ; READER, Michael ; BAGULEY, Paul Anthony ; MELLING, Robert Craig ; SCARATI, Mirka ; SAUNDERS, Mark Henry ; ADAMCZYK, Bozena Ewa</creator><creatorcontrib>WILSHER, Nicola Elizabeth ; LINDLEY, Colin Thomas ; READER, Michael ; BAGULEY, Paul Anthony ; MELLING, Robert Craig ; SCARATI, Mirka ; SAUNDERS, Mark Henry ; ADAMCZYK, Bozena Ewa</creatorcontrib><description>This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4 -yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and synthetic intermediates for use in the process, and novel formulations containing the compound, as well as therapeutic uses of the compound.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240828&DB=EPODOC&CC=EP&NR=3612524B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240828&DB=EPODOC&CC=EP&NR=3612524B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WILSHER, Nicola Elizabeth</creatorcontrib><creatorcontrib>LINDLEY, Colin Thomas</creatorcontrib><creatorcontrib>READER, Michael</creatorcontrib><creatorcontrib>BAGULEY, Paul Anthony</creatorcontrib><creatorcontrib>MELLING, Robert Craig</creatorcontrib><creatorcontrib>SCARATI, Mirka</creatorcontrib><creatorcontrib>SAUNDERS, Mark Henry</creatorcontrib><creatorcontrib>ADAMCZYK, Bozena Ewa</creatorcontrib><title>6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR</title><description>This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4 -yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and synthetic intermediates for use in the process, and novel formulations containing the compound, as well as therapeutic uses of the compound.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAx0w2IDPL09XTx9NP1DPb39HPx93FVcHEN8gxzDPEMc1VwDFZwDfI21DdS8PTz8HTyDPEP4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxmaGRqZGJk6GxkQoAQBnsibB</recordid><startdate>20240828</startdate><enddate>20240828</enddate><creator>WILSHER, Nicola Elizabeth</creator><creator>LINDLEY, Colin Thomas</creator><creator>READER, Michael</creator><creator>BAGULEY, Paul Anthony</creator><creator>MELLING, Robert Craig</creator><creator>SCARATI, Mirka</creator><creator>SAUNDERS, Mark Henry</creator><creator>ADAMCZYK, Bozena Ewa</creator><scope>EVB</scope></search><sort><creationdate>20240828</creationdate><title>6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR</title><author>WILSHER, Nicola Elizabeth ; LINDLEY, Colin Thomas ; READER, Michael ; BAGULEY, Paul Anthony ; MELLING, Robert Craig ; SCARATI, Mirka ; SAUNDERS, Mark Henry ; ADAMCZYK, Bozena Ewa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3612524B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WILSHER, Nicola Elizabeth</creatorcontrib><creatorcontrib>LINDLEY, Colin Thomas</creatorcontrib><creatorcontrib>READER, Michael</creatorcontrib><creatorcontrib>BAGULEY, Paul Anthony</creatorcontrib><creatorcontrib>MELLING, Robert Craig</creatorcontrib><creatorcontrib>SCARATI, Mirka</creatorcontrib><creatorcontrib>SAUNDERS, Mark Henry</creatorcontrib><creatorcontrib>ADAMCZYK, Bozena Ewa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WILSHER, Nicola Elizabeth</au><au>LINDLEY, Colin Thomas</au><au>READER, Michael</au><au>BAGULEY, Paul Anthony</au><au>MELLING, Robert Craig</au><au>SCARATI, Mirka</au><au>SAUNDERS, Mark Henry</au><au>ADAMCZYK, Bozena Ewa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR</title><date>2024-08-28</date><risdate>2024</risdate><abstract>This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4 -yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide, and in particular to novel physical forms of the compound, a process for preparing the compound and synthetic intermediates for use in the process, and novel formulations containing the compound, as well as therapeutic uses of the compound.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3612524B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T20%3A54%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WILSHER,%20Nicola%20Elizabeth&rft.date=2024-08-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3612524B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |